Severe phenotype of Morquio A disease in a child with S287L N-acetylgalactosamine-6-sulfate sulfatase mutation

被引:0
|
作者
Gucev, Zoran S. [1 ]
Bouzidi, Hassan [2 ]
Tasic, Velibor [1 ]
Popjordanova, Nada [1 ]
Kirovski, Ilija [1 ]
Trajkovski, Zoran [2 ]
Jancevska, Aleksandra [1 ]
Bajrami, Sami [1 ]
机构
[1] Univ Hosp Sick Children, Sch Med, Skopje 1000, Fyrom, Macedonia
[2] Tahar Sfar Hosp, Biochem Lab, Mahdia 5100, Tunisia
来源
关键词
Morquio A disease; N-acetyl galactosamine-6-sulphate sulfatase; S287L mutation; severe phenotype;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mucopolysaccharidosis IVA is caused by a deficiency of lysosomal N-acetyl-galactosamine-6-sulfate sulfatase (GALNS; E.C.3.1.6.4). One hundred fourty-eight GALNS mutations were described in patients with different phenotype severity. Our patient was a 6.5 year old boy with severe kyphoscoliosis and growth delay. He developed coarsening of the facial features and megalencephaly. Both corneas were cloudy. His gait was difficult with limited and painful movements in the hips, the spine and the knees. X-ray studies showed platispondily with ovoid vertebrae, bulging sternum and flaring of the rib cage. The long bones were short with irregular trabeculation. Metaphyses were widened, femoral head was flattened. The metacarpals had conical bases. Total excretion of glycosaminoglycans (GAG) in urine was increased. Thin layer chromatography of urinary GAG showed massive excretion of keratan sulphate. N-acetyl Galactosamine-6-sulphate sulfatase activity in leukocytes was low (0.7 nmol/MU17h/mg protein). DNA sequencing detected a S287L, mutation (c.860C>Tc.860 C>T). This is the first GALNS mutation described in our population. The same mutation conferred a severe NIPS IVA phenotype in a American, Austrian and Polish patients.
引用
收藏
页码:383 / 386
页数:4
相关论文
共 50 条
  • [21] Mouse model of N-acetylgalactosamine-6-sulfate sulfatase deficiency (Galns-/-) produced by targeted disruption of the gene defective in Morquio A disease
    Tomatsu, S
    Orii, KO
    Vogler, C
    Nakayama, J
    Levy, B
    Grubb, JH
    Gutierrez, MA
    Shim, S
    Yamaguchi, S
    Nishioka, T
    Montaño, AM
    Noguchi, A
    Orii, T
    Kondo, N
    Sly, WS
    HUMAN MOLECULAR GENETICS, 2003, 12 (24) : 3349 - 3358
  • [22] Mucopolysaccharidosis IVA: A novel splice acceptor site mutation in intron 4 of the N-acetylgalactosamine-6-sulfate sulfatase gene in an Afghanistan girl with classical Morquio disease
    Fukuda, S
    Yamada, N
    Tomatsu, S
    Sukegawa, K
    Montano, AM
    Hopwood, JJ
    Muller, V
    Orii, T
    Kondo, N
    JAPANESE JOURNAL OF HUMAN GENETICS, 1997, 42 (02) : 317 - 322
  • [23] Recombinant N-acetylgalactosamine-6-sulfate sulfatase (GALNS) enzyme produced in pichia pastoris as an alternative for Morquio syndrome type A ERT
    Rodriguez-Lopez, Alexander
    Pimentel-Vera, Luisa N.
    Espejo-Mojica, Angela J.
    Hidalgo, Oscar A.
    Tomatsu, Shunji
    Almeciga-Diaz, Carlos J.
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S123 - S123
  • [24] MUCOPOLYSACCHARIDOSIS TYPE-IVA - N-ACETYLGALACTOSAMINE-6-SULFATE SULFATASE EXONIC POINT MUTATIONS IN CLASSICAL MORQUIO AND MILD CASES
    FUKUDA, S
    TOMATSU, S
    MASUE, M
    SUKEGAWA, K
    IWATA, H
    OGAWA, T
    NAKASHIMA, Y
    HORI, T
    YAMAGISHI, A
    HANYU, Y
    MOROOKA, K
    KIMAN, T
    HASHIMOTO, T
    ORII, T
    JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (03): : 1049 - 1053
  • [25] LATE ONSET N-ACETYLGALACTOSAMINE-6-SULFATE SULFATASE DEFICIENCY IN 2 BROTHERS
    ORII, T
    SUKEGAWA, K
    TAGA, T
    JAPANESE JOURNAL OF HUMAN GENETICS, 1982, 27 (02): : 138 - 138
  • [26] Characterization and pharmacokinetic study of recombinant human N-acetylgalactosamine-6-sulfate sulfatase
    Tomatsu, Shunji
    Montano, Adriana M.
    Gutierrez, Monica
    Grubb, Jeffrey H.
    Oikawa, Hirotaka
    Dung, Vu Chi
    Ohashi, Amiko
    Nishioka, Tatsuo
    Yamada, Masamichi
    Yamada, Maria
    Tosaka, Yasuhiro
    Trandafirescu, Georgeta G.
    Orii, Tadao
    MOLECULAR GENETICS AND METABOLISM, 2007, 91 (01) : 69 - 78
  • [27] Production of recombinant human N-acetylgalactosamine-6-sulfate sulfatase enzyme in Pichia pastoris
    Rodriguez, Alexander
    Moreno, Jefferson
    Sanchez, Jhonnathan
    Diaz, Dennis
    Beltran, Laura
    Espejo, Angela
    Almeciga, Carlos
    Barrera, Luis
    MOLECULAR GENETICS AND METABOLISM, 2013, 108 (02) : S79 - S80
  • [28] Enzyme replacement therapy for Morquio A: an active recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in Escherichia coli BL21
    Rodriguez, Alexander
    Espejo, Angela J.
    Hernandez, Alejandra
    Velasquez, Olga L.
    Lizaraso, Lina M.
    Cordoba, Henry A.
    Sanchez, Oscar F.
    Almeciga-Diaz, Carlos J.
    Barrera, Luis A.
    JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY, 2010, 37 (11) : 1193 - 1201
  • [29] Molecular Analysis of Turkish Mucopolysaccharidosis IVA (Morquio A) Patients: Identification of Novel Mutations in the N-acetylgalactosamine-6-sulfate sulfatase (GALNS) Gene
    Terzioglu, Mugen
    Tokatli, Aysegul
    Coskun, Turgay
    Emre, Serap
    HUMAN MUTATION, 2002, 20 (06) : 477 - 478
  • [30] Mucopolysaccharidosis IVA: Submicroscopic deletion of 16q24.3 and a novel R386C mutation of N-acetylgalactosamine-6-sulfate sulfatase gene in a classical Morquio disease
    Fukuda, S
    Tomatsu, S
    Masuno, M
    Ogawa, T
    Yamagishi, A
    Rezvi, GMM
    Sukegawa, K
    Shimozawa, N
    Suzuki, Y
    Kondo, N
    Imaizumi, K
    Kuroki, Y
    Okabe, T
    Orii, T
    HUMAN MUTATION, 1996, 7 (02) : 123 - 134